Choksi Laboratories Ltd

Annual General Meeting

Choksi Laboratories Annual General Meeting

Choksi Laboratories Ltd has scheduled an EGM for October 17, 2026, to seek shareholder approval for issuing 3.50 lakh convertible warrants at ₹177 per warrant.

Value

₹6.20 Cr

Capital Structure Change

Choksi Laboratories Capital Structure Change

Choksi Laboratories board approved a preferential issue of 3.5 lakh warrants to promoters at Rs 177 per warrant, totaling Rs 6.195 Crore.

Value

₹6.20 Cr

Annual General Meeting

Choksi Laboratories Annual General Meeting

Choksi Laboratories filed proceedings of its 33rd AGM held on 18 September 2026. Directors Sunil Choksi and Himika Choksi were re-appointed as Whole-Time Directors.

Board Meeting Date

Choksi Laboratories Board Meeting Date

Choksi Laboratories announced a Board meeting on September 19, 2026, to discuss a proposal for raising funds through equity or convertible securities.

Financial Results

Choksi Laboratories Q1 FY27 Results: Net Profit ₹0.6 Cr, Up 50.0% YoY

Choksi Laboratories Ltd reported revenue from operations of ₹12.1 Cr (+8.0% YoY) and net profit of ₹0.6 Cr (+50.0% YoY) for Q1 FY27.

Key figure

Net profit ₹0.6 Cr · +50.0% YoY

Financial Results

Choksi Laboratories Q4 FY26 Results: Net Profit ₹1 Cr, Up 11.1% YoY

Choksi Laboratories Ltd reported revenue from operations of ₹12.8 Cr (+12.3% YoY) and net profit of ₹1 Cr (+11.1% YoY) for Q4 FY26.

Key figure

Net profit ₹1 Cr · +11.1% YoY